Genor Biopharma Holdings Limited (FRA:67N0)
Germany · Delayed Price · Currency is EUR 0.3780
+0.0220 (6.18%)
At close: Nov 26, 2025
Genor Biopharma Holdings Market Cap
Genor Biopharma Holdings has a market cap or net worth of €196.48 million as of December 1, 2025. Its market cap has increased by 74.33% in one year.
Market Cap
196.48M
Enterprise Value
74.35M
Revenue
26.63M
Ranking
n/a
PE Ratio
57.16
Stock Price
€0.38
Market Cap Chart
Since October 7, 2020, Genor Biopharma Holdings's market cap has decreased from 1.47B to 196.48M, a decrease of -86.67%. That is a compound annual growth rate of -32.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 196.48M | 76.80% |
| Dec 31, 2024 | 111.13M | 60.08% |
| Dec 29, 2023 | 69.42M | -56.42% |
| Dec 30, 2022 | 159.30M | -60.24% |
| Dec 31, 2021 | 400.69M | -61.30% |
| Dec 31, 2020 | 1.04B | -29.77% |
| Oct 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |